Company profile: Centese
1.1 - Company Overview
Company description
- Provider of cardiothoracic post-operative medical equipment for surgical care and patient monitoring, including Thoraguard, a compact all-in-one system with digital monitor, suction control, canister, and chest tubes. Features automated chest tube clog clearance, precise digital air leak rate monitoring, hourly drainage volume trends, and self-monitoring alerts for cardiac and thoracic surgery.
Products and services
- Automated Clog Clearance System: An automated mechanism clearing chest tube clogs without manual intervention during cardiac surgery, enhancing patient safety and monitoring in the post-operative setting
- Digital Air Leak Monitoring: A digital measurement system quantifying air leak rates and trends, delivering objective data to aid patient discharge decisions following cardiothoracic surgery
- Thoraguard: A digital system for cardiothoracic care that automates chest tube clearance and tracks air leak rates and drainage volumes to support objective patient management
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Centese
Occlutech
HQ: Sweden
Website
- Description: Provider of cardiac occlusion devices and other vascular implants, offering the PFO Occluder for patent foramen ovale closure to reduce recurrent stroke, the UNI Occluder for multi-fenestrated atrial septal defects as a surgical alternative, and accessory tools (Pistol Pusher, Flex-II Pusher) for device implantation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Occlutech company profile →
Spectrum Dynamics Medical
HQ: United States
Website
- Description: Provider of innovative high definition functional imaging technology that delivers high-speed, high-resolution nuclear images in compact systems designed to meet clinical and workflow demands, including BroadView™ Technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spectrum Dynamics Medical company profile →
3F Therapeutics
HQ: United States
Website
- Description: Provider of cardiovascular devices and invasive and transapical aortic heart replacement technology, including enabling aortic heart valve, entrata aortic valve system, and endurance valve system, to reduce surgical cross-clamp and cardio-pulmonary bypass time, with utilization for congestive heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3F Therapeutics company profile →
NeoChord
HQ: United States
Website
- Description: Provider of devices and services for mitral valve repair on a beating heart, including the NeoChord DS1000 System for echo-guided restoration of damaged mitral valve chords through a small incision; NeoChord ConsultConnect and ConnectCARD consultation services for delivery of artificial chordae tendineae to aid treatment of mitral insufficiency; and the Transcatheter Transseptal NeoChord NeXuS for MRI safety under specific conditions post-treatment with NeoChord devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeoChord company profile →
RhythMedix
HQ: United States
Website
- Description: Provider of cardiac diagnostics and monitoring solutions, including RhythmStar wearable ECG monitor with built-in 4G cellular connectivity for continuous monitoring and compliance checks, mobile cardiac telemetry, extended wear Holter (3–15 days), Holter monitoring (24–48 hours), event monitoring, and RhythmConnect patient portal to enroll, track, and manage patients, supported by outstanding service, support, and patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RhythMedix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Centese
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Centese
2.2 - Growth funds investing in similar companies to Centese
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Centese
4.2 - Public trading comparable groups for Centese
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →